Breaking News

MabPlex to Expand CDMO Services

Biologics CDMO secures $59.1 Million series A financing round

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

MabPlex International, a contract development and manufacturing organization (CDMO) serving the global biopharmaceutical and biotechnology industries with sites in China and the U.S., has closed its series A funding of $59.1 million backed by multiple global investors led by China’s State Development & Investment Corporation (SDIC) and Shenzhen Venture capital.    This financing round will support upgrades to MabPlex’s technology platform, Phase III and commercial production ex...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters